Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ATRNYSE:SNN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeATRAptarGroup$161.09+0.5%$154.21$130.85▼$178.03$10.64B0.57322,791 shs235,097 shsSNNSmith & Nephew SNATS$30.26+0.3%$29.07$23.69▼$31.72$13.26B0.69808,053 shs274,870 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceATRAptarGroup0.00%+3.36%+5.70%+14.99%+14.07%SNNSmith & Nephew SNATS0.00%+0.05%-0.15%+14.92%+20.41%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationATRAptarGroup4.7655 of 5 stars2.55.04.22.33.22.51.3SNNSmith & Nephew SNATS3.7326 of 5 stars1.05.02.50.03.30.04.4Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceATRAptarGroup 3.00Buy$178.6010.87% UpsideSNNSmith & Nephew SNATS 2.00Hold$28.00-7.47% DownsideCurrent Analyst Ratings BreakdownLatest ATR, ENQ, RAT, and SNN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/6/2025ATRAptarGroupWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$162.00 ➝ $170.005/1/2025SNNSmith & Nephew SNATSCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$27.00 ➝ $28.004/25/2025SNNSmith & Nephew SNATSHsbc Global ResSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold4/25/2025SNNSmith & Nephew SNATSHSBCSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold4/22/2025ATRAptarGroupRaymond James FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$190.00 ➝ $175.00(Data available from 7/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookATRAptarGroup$3.58B2.97$9.70 per share16.60$37.36 per share4.31SNNSmith & Nephew SNATS$5.81B2.28$3.16 per share9.59$12.04 per share2.51Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateATRAptarGroup$374.54M$5.4829.4025.823.3110.41%15.10%8.37%7/31/2025 (Estimated)SNNSmith & Nephew SNATS$412M$2.1614.0115.130.93N/AN/AN/A8/5/2025 (Estimated)Latest ATR, ENQ, RAT, and SNN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/31/2025Q2 2025ATRAptarGroup$1.59N/AN/AN/A$954.06 millionN/A5/1/2025Q1 2025ATRAptarGroup$1.16$1.20+$0.04$1.17$894.26 million$887.31 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthATRAptarGroup$1.801.12%N/A32.85%31 YearsSNNSmith & Nephew SNATS$0.892.94%N/A41.20%N/ALatest ATR, ENQ, RAT, and SNN DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/17/2025ATRAptarGroupquarterly$0.451.25%5/1/20255/1/20255/22/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioATRAptarGroup0.221.250.85SNNSmith & Nephew SNATS0.622.891.33Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipATRAptarGroup88.52%SNNSmith & Nephew SNATS25.64%Insider OwnershipCompanyInsider OwnershipATRAptarGroup0.68%SNNSmith & Nephew SNATS1.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableATRAptarGroup13,50066.04 million65.59 millionOptionableSNNSmith & Nephew SNATS17,349437.97 million433.59 millionOptionableATR, ENQ, RAT, and SNN HeadlinesRecent News About These CompaniesSmith & Nephew SNATS, Inc. (NYSE:SNN) Shares Acquired by Oppenheimer Asset Management Inc.June 28, 2025 | marketbeat.comSNN Expands Orthopedic Portfolio With Advanced Tibia Nailing SystemJune 26, 2025 | zacks.comSNN vs. GEHC: Which Stock Is the Better Value Option?June 25, 2025 | zacks.comIs Smith & Nephew SNATS (SNN) Stock Undervalued Right Now?June 25, 2025 | zacks.comSmith & Nephew SNATS (NYSE:SNN) Sees Unusually-High Trading Volume - Time to Buy?June 24, 2025 | marketbeat.comSmith+Nephew's new TRIGEN™ MAX Tibia Nailing System brings ‘next-level nailing' to trauma surgeons repairing tibial fracturesJune 24, 2025 | globenewswire.comScharf Investments LLC Sells 555,004 Shares of Smith & Nephew SNATS, Inc. (NYSE:SNN)June 23, 2025 | marketbeat.comAjay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy OfficerJune 23, 2025 | globenewswire.comSmith+Nephew Stock May Gain From Strategic Deal With Standard HealthJune 20, 2025 | zacks.comSmith+Nephew and Standard Health partner on first Orthopaedic Ambulatory Surgery Centre in the UKJune 18, 2025 | globenewswire.comSmith & Nephew plc (NYSE:SNN) Sees Significant Increase in Short InterestJune 16, 2025 | marketbeat.comLorne Steinberg Wealth Management Inc. Boosts Position in Smith & Nephew plc (NYSE:SNN)June 16, 2025 | marketbeat.comPark Avenue Securities LLC Acquires Shares of 9,206 Smith & Nephew plc (NYSE:SNN)June 16, 2025 | marketbeat.comSmith & Nephew plc (NYSE:SNN) Given Average Recommendation of "Hold" by BrokeragesJune 14, 2025 | marketbeat.comSmith & Nephew plc (NYSE:SNN) Shares Purchased by GAMMA Investing LLCJune 13, 2025 | marketbeat.comWealth Enhancement Advisory Services LLC Takes Position in Smith & Nephew plc (NYSE:SNN)June 10, 2025 | marketbeat.comNew medial stabilized insert for Smith+Nephew's LEGION™ Total Knee System designed to improve kinematics, stability and procedural versatilityJune 9, 2025 | globenewswire.comClean Yield Group Sells 150,568 Shares of Smith & Nephew plc (NYSE:SNN)June 8, 2025 | marketbeat.comSmith & Nephew (SN) Receives a Buy from CitiJune 7, 2025 | theglobeandmail.comSmith & Nephew plc (NYSE:SNN) Shares Purchased by NBC Securities Inc.June 6, 2025 | marketbeat.comSmith & Nephew SNATS, Inc. Common Stock (SNN)May 31, 2025 | nasdaq.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesIntel's Turnaround Strategy Shifts From Planning to Attack ModeBy Jeffrey Neal Johnson | June 20, 2025View Intel's Turnaround Strategy Shifts From Planning to Attack Mode3 Catalysts in 7 Days: Archer's Growth Story Just AcceleratedBy Jeffrey Neal Johnson | June 18, 2025View 3 Catalysts in 7 Days: Archer's Growth Story Just AcceleratedGovernment Mandate Sends eVTOL Stocks FlyingBy Jeffrey Neal Johnson | June 10, 2025View Government Mandate Sends eVTOL Stocks FlyingHow a Government Loan Changes the Game for Plug PowerBy Jeffrey Neal Johnson | July 4, 2025View How a Government Loan Changes the Game for Plug PowerAddition by Subtraction: Intel’s New Strategy Energizes InvestorsBy Jeffrey Neal Johnson | June 27, 2025View Addition by Subtraction: Intel’s New Strategy Energizes InvestorsATR, ENQ, RAT, and SNN Company DescriptionsAptarGroup NYSE:ATR$161.09 +0.77 (+0.48%) Closing price 07/3/2025 03:40 PM EasternExtended Trading$161.09 0.00 (0.00%) As of 07/3/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, and aerosol valves to the digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.Smith & Nephew SNATS NYSE:SNN$30.26 +0.10 (+0.33%) As of 07/3/2025 03:56 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
